Journal of Nephropathology最新文献

筛选
英文 中文
COVID-19 clinical manifestations on different gender reproductive system 新冠肺炎不同性别生殖系统的临床表现
Journal of Nephropathology Pub Date : 2022-07-20 DOI: 10.34172/jnp.2022.17326
Masoud Bitaraf, Yekta Rahimi, Ramezan Jafari, Fereshte Aliakbari, Layla Shojaie, F. Saleh, Fatemeh Rezaei-Tazangi, Masoumeh Majidi Zolbin
{"title":"COVID-19 clinical manifestations on different gender reproductive system","authors":"Masoud Bitaraf, Yekta Rahimi, Ramezan Jafari, Fereshte Aliakbari, Layla Shojaie, F. Saleh, Fatemeh Rezaei-Tazangi, Masoumeh Majidi Zolbin","doi":"10.34172/jnp.2022.17326","DOIUrl":"https://doi.org/10.34172/jnp.2022.17326","url":null,"abstract":"Coronavirus disease 2019 (COVID-19) is a major threat to world health and safety, making it the primary concern of global community that requires immediate preventive measures. Several organs are affected by this disease simultaneously with possible long-lasting sequelae. Disease pathogenesis is influenced by, the type of virus and its mutation, the number of viruses, individual’s immune system and their age, gender, nutritional status, homeostasis between the immune, nervous and endocrine systems, and also physical condition. All of these factors play a role in the onset, duration, severity, and recurrence of the disease. Since the exact mechanism of infection with this virus is not fully understood, in this study we aimed to investigate its effects on the reproductive system in male and female as well as pregnancy outcome.","PeriodicalId":16515,"journal":{"name":"Journal of Nephropathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46896707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful pregnancy in an end-stage renal disease woman on chronic hemodialysis 慢性血液透析治疗终末期肾病妇女的成功妊娠
Journal of Nephropathology Pub Date : 2022-07-20 DOI: 10.34172/jnp.2022.18387
F. Yaghoubi, F. Tavakoli, Davood Dalil, Saeid Iranzadeh
{"title":"Successful pregnancy in an end-stage renal disease woman on chronic hemodialysis","authors":"F. Yaghoubi, F. Tavakoli, Davood Dalil, Saeid Iranzadeh","doi":"10.34172/jnp.2022.18387","DOIUrl":"https://doi.org/10.34172/jnp.2022.18387","url":null,"abstract":"Successful conception in a female patient on hemodialysis (HD) is considered a high-risk pregnancy and associated with maternal and fetal complications. Thus, most such pregnancies lead to abortion or termination to preserve maternal health. Here, we report a successfully-delivered case of a 19th-week-diagnosed pregnancy in a 35-year-old mother with end-stage renal disease (ESRD). We present the case of a 35-year-old female with ESRD, diagnosed 10 years ago secondary to glomerulonephritis. The patient underwent the deceased–donor renal transplantation once, which unfortunately was rejected. During the initial tests for second-time kidney transplantation, a human chorionic gonadotropin-beta (beta-hCG) positive with a level of 9953 mIU/mL was reported, suggesting the pregnancy. The transvaginal ultrasonography confirmed the pregnancy at an approximate gestational age of 19 weeks. As a result, the patient underwent four and half hours of intensive HD five times a week and continued until 36 weeks of pregnancy. At 36 weeks, the patient presented to Shariati hospital, Tehran, Iran, with low- back pain. Consequently, a cesarean section (C/S) was performed, and the baby boy was born with a nine of ten Apgar score. Although successful pregnancy is possible for women with ESRD, it requires special multidisciplinary care. Intensive HD and regular fetal monitoring have improved the pregnancy outcome in this population. However, the risk of severe complications is still for the health of the mother and her offspring.","PeriodicalId":16515,"journal":{"name":"Journal of Nephropathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43350478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A renal transplant patient with COVID-19 presented with acute cellular rejection 一名新冠肺炎肾移植患者出现急性细胞排斥反应
Journal of Nephropathology Pub Date : 2022-07-20 DOI: 10.34172/jnp.2022.18389
N. Soleimani, S. Mohammadzadeh
{"title":"A renal transplant patient with COVID-19 presented with acute cellular rejection","authors":"N. Soleimani, S. Mohammadzadeh","doi":"10.34172/jnp.2022.18389","DOIUrl":"https://doi.org/10.34172/jnp.2022.18389","url":null,"abstract":"A 27-year-old man underwent a deceased kidney transplant. Three days after transplantation, COVID-19 was diagnosed for our patient. Immunosuppressants were reduced and a renal biopsy was conducted, which showed acute T cell-mediated rejection. We intened to share a case to help clinicians to understand the risks that kidney transplant recipients face.","PeriodicalId":16515,"journal":{"name":"Journal of Nephropathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42321206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Risk stratification and long-term kidney survival in IgA nephropathy with particular emphasis on Oxford classification; A narrative review IgA肾病的风险分层和长期肾脏生存,特别强调牛津分级叙述性回顾
Journal of Nephropathology Pub Date : 2022-07-20 DOI: 10.34172/jnp.2022.18395
Lisa Aimee Hechanova, M. Mubarak, Dorsa Jahangiri, J. Bilbao, Leila Mostafavi, Tella Sadighpour, R. Tolouian
{"title":"Risk stratification and long-term kidney survival in IgA nephropathy with particular emphasis on Oxford classification; A narrative review","authors":"Lisa Aimee Hechanova, M. Mubarak, Dorsa Jahangiri, J. Bilbao, Leila Mostafavi, Tella Sadighpour, R. Tolouian","doi":"10.34172/jnp.2022.18395","DOIUrl":"https://doi.org/10.34172/jnp.2022.18395","url":null,"abstract":"Introduction: IgA nephropathy (IgAN) is one of the most common forms of glomerulonephritis worldwide. It leads to end-stage renal disease (ESRD) in many patients. At the time of diagnosis, risk stratification is of paramount importance in planning proper management in individual cases. Several studies have been conducted to determine the utility of various demographic, clinical, laboratory, and pathological features on renal biopsy to stratify the risk of disease progression and predict the likely outcome. This review summarizes the emerging data on demographic, clinical, laboratory, and histological prognosis along with risk factors associated with renal outcomes in patients with IgAN. Methods: For this review, we searched DOAJ (Directory of Open Access Journals), PubMed/Medline, Web of Science, Scopus, Embase, and Google Scholar, using keywords including; \"IgA nephropathy,\" \"IgA nephritis,\" \"IgAN,\" \"Berger’s disease,\" \"Berger’s syndrome,\" \"chronic glomerulonephritis, \"prognostic factors,\" \"risk factors,\" \"risk stratification,\" \"renal survival,\" \"ESRD,\" \"MEST classification,\" \"MEST-C classification\" and \"Oxford Classification.\" To identify other relevant studies, we manually scanned the bibliographic lists of the identified studies and reviewed articles from January 2009 through December 2020. All relevant articles were carefully reviewed, and relevant information was extracted for this narrative review. Results: A total of 152 articles were retrieved from the above literature database searches. The abstracts were carefully reviewed to identify 35 articles containing information on prognostic factors and longterm renal survival in IgAN patients. Relevant information was collected and summarized for this review. The main focus was on using demographic, clinical, and laboratory features, especially serial changes in these parameters during follow-up, for this purpose. Recently a standardized, evidencebased formulation has been devised to evaluate and categorize pathological features on renal biopsy to augment and refine the risk stratification and prognostic value of traditional risk factors; it is popularly known as the Oxford classification of IgAN. There have been numerous validation studies in various ethnic groups that have proven its clinical utility. Conclusion: In conclusion, the clinicians should also take into account the pathologic variables according to the revised Oxford classification in addition to demographic, clinical, and laboratory parameters for early and reliable risk stratification and prognostication in individual patients at the time of diagnosis in IgAN for optimal management and ultimate improvement in long-term outcomes.","PeriodicalId":16515,"journal":{"name":"Journal of Nephropathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44747682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of pharmacists in the management of AKI patients: What recent studies added to our knowledge? 药剂师在AKI患者管理中的作用:最近的研究增加了我们的知识?
Journal of Nephropathology Pub Date : 2022-07-02 DOI: 10.34172/jnp.2022.17360
A. R. F. Nahas
{"title":"The role of pharmacists in the management of AKI patients: What recent studies added to our knowledge?","authors":"A. R. F. Nahas","doi":"10.34172/jnp.2022.17360","DOIUrl":"https://doi.org/10.34172/jnp.2022.17360","url":null,"abstract":"Introduction: Acute kidney injury (AKI) is a complex syndrome requiring special management. It also complicates the prognosis of many hospitalized patients. Some essential yet nephrotoxic medications and the use of certain procedures that may alter renal hemodynamics further complicate the management of AKI patients. Fortunately, as part of the renal care team, pharmacists can have a significant role in the multidisciplinary approach used to optimize renal patients’ health-related quality of life by delivering safe and effective pharmaceutical care. Objective: The present review aims to explore pharmacists’ contributions to the management of patients with AKI as well as their influence on improving renal patients’ care. Methods: An online search was performed in the databases PubMed, Scopus, and ScienceDirect for relevant articles published in English between 1 January 2015 and 31 December 2021. Review articles, books, guidelines, websites, and conference proceedings were excluded. Results: Only 12 articles out of 51 initially gathered met the eligibility criteria for this review. The three main roles that pharmacists play in the management of AKI patients are patients’ education, collaborating with other renal care practitioners, and identifying and solving drug-related problems (DRPs). The latter task span includes medication reconciliation, dosage adjustments, and identifying adverse drug reactions. Conclusion: In view of the complexity of the AKI course, trained pharmacists, as members of the renal care team, can play a pivotal role in managing AKI patients and minimizing their medications burden. This can positively impact the overall renal care process as well as the patient’s outcome. Further studies can provide more support to the importance of pharmacists’ role in managing AKI.","PeriodicalId":16515,"journal":{"name":"Journal of Nephropathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43408336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Take a closer look at TINU syndrome; analysis of a case 仔细看看TINU综合症;案例分析
Journal of Nephropathology Pub Date : 2022-06-28 DOI: 10.34172/jnp.2022.17349
Eduarda Carias, A. Cabrita, P. Neves, A. P. Silva
{"title":"Take a closer look at TINU syndrome; analysis of a case","authors":"Eduarda Carias, A. Cabrita, P. Neves, A. P. Silva","doi":"10.34172/jnp.2022.17349","DOIUrl":"https://doi.org/10.34172/jnp.2022.17349","url":null,"abstract":"Tubulointerstitial nephritis and uveitis syndrome (TINU) combines tubulointerstitial nephritis and uveitis and is a known cause of kidney failure in children and adults. This is a challenging diagnosis since renal and ocular manifestations may not occur simultaneously and may be present in several alternative diagnosis. The authors report the case of a 28-year-old patient with acute kidney injury (AKI) and biopsy-proven acute tubulointerstitial nephritis. Bilateral symptomatic uveitis presented six months after the initial presentation. Physicians in charge of patients with kidney disease attributed to acute tubulointerstitial nephritis must bear in mind the need for ophthalmologic surveillance for at least one year post-diagnosis. Although a diagnosis of exclusion, its incidence may be higher than described. Kidney disease is believed to be self-limited and prognosis still, most patients will require systemic therapy and relapses are common.","PeriodicalId":16515,"journal":{"name":"Journal of Nephropathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47144365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of hyponatremia in hospitalized patients with coronavirus disease 2019; a multicenter study 2019冠状病毒病住院患者低钠血症的患病率;一项多中心研究
Journal of Nephropathology Pub Date : 2022-06-09 DOI: 10.34172/jnp.2022.18383
S. Hajian, Ali Sarbazi-Golezari, M. Karbasi
{"title":"Prevalence of hyponatremia in hospitalized patients with coronavirus disease 2019; a multicenter study","authors":"S. Hajian, Ali Sarbazi-Golezari, M. Karbasi","doi":"10.34172/jnp.2022.18383","DOIUrl":"https://doi.org/10.34172/jnp.2022.18383","url":null,"abstract":"Introduction: In patients with coronavirus disease 2019 (COVID-19), the prevalence of hyponatremia has been reported with varying outcomes. Objectives: The aim of this study was to evaluate the prevalence of hyponatremia in hospitalized patients with COVID-19. Patients and Methods: In this multicenter cross-sectional study, information about hospitalized patients with COVID-19 admitted between March 2020 and September 2020, including age, gender, and serum levels of sodium, creatinine, and potassium, as well as blood urea nitrogen (BUN), was analyzed, while P value level less than 0.05 was considered significant. Results: A total of 667 hospitalized patients with COVID-19 were enrolled in the study, of which 54.4% were male. The median age of patients was 63 years old. About 39.4% of patients had hyponatremia on admission day. More than 80% of patients had mild hyponatremia. The median age of the hyponatremia group was significantly higher than that of eunatremia group. Conclusion: Our data showed that hyponatremia is observed in hospitalized patients with COVID-19 and is often mild.","PeriodicalId":16515,"journal":{"name":"Journal of Nephropathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47478351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protocol for systematic review and meta-analysis on the effect of natural products use on blood pressure in Iran 伊朗天然产品使用对血压影响的系统综述和荟萃分析方案
Journal of Nephropathology Pub Date : 2022-06-05 DOI: 10.34172/jnp.2022.17290
Mohammadkarim Azadbakht, A. Fatahian, S. Yousefi, M. Moosazadeh, M. Fakhri
{"title":"Protocol for systematic review and meta-analysis on the effect of natural products use on blood pressure in Iran","authors":"Mohammadkarim Azadbakht, A. Fatahian, S. Yousefi, M. Moosazadeh, M. Fakhri","doi":"10.34172/jnp.2022.17290","DOIUrl":"https://doi.org/10.34172/jnp.2022.17290","url":null,"abstract":"Background: Today, hypertension is a significant public health problem globally, widely recognized as a major risk factor for death. Blood pressure-lowering herbal medicines and natural products have been used for centuries. The protocol aims to determine the effect of natural product use on blood pressure in Iran using data from previously published randomized controlled trials. The current protocol for a systematic review and meta-analysis is designed to determine the effect of natural product use on blood pressure in Iran. Methods: The protocol is developed using PICO (participants, interventions, comparisons, and outcomes) items to assess the effect of natural products on blood pressure reduction in randomized clinical trials (RCTs) in Iran. Specific MESH terms will be used to search Google Scholar, PubMed, and the Cochrane Central Register for randomized controlled clinical trials, as well as national databases such as Barekat Gostar, SID, Magiran, and IranDoc. The I2 index and the Q-test will be used to examine heterogeneity in the effect sizes of individual studies. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) of RCTs will be reported per Cochrane guidelines, and all forms will be based on validated Cochrane templates. Discussion: This protocol will detail the effects of natural products (interventions) in comparison to a placebo or other control group (comparators). Registration: The current protocol was also registered on PROSPERO (ID: CRD42021231837, https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=231837, Date: February 18, 2021).","PeriodicalId":16515,"journal":{"name":"Journal of Nephropathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44154875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Tubulointerstitial Nephritis Following COVID-19 mRNA Vaccine: Case Report COVID-19 mRNA疫苗后急性肾小管间质性肾炎1例报告
Journal of Nephropathology Pub Date : 2022-05-31 DOI: 10.34172/jnp.2022.17369
G. Kantarci, E. Hacıhasanoğlu, A. Şekuri, Batuhan Oguz, Senay Acikel
{"title":"Acute Tubulointerstitial Nephritis Following COVID-19 mRNA Vaccine: Case Report","authors":"G. Kantarci, E. Hacıhasanoğlu, A. Şekuri, Batuhan Oguz, Senay Acikel","doi":"10.34172/jnp.2022.17369","DOIUrl":"https://doi.org/10.34172/jnp.2022.17369","url":null,"abstract":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes Coronavirus disease-19 (COVID-19) continues to affect the world, as studies for vaccinations and treatments gather speed. One of the many types of COVID-19 vaccines is messenger RNA (mRNA) vaccine, which contains the selected sequence of the viral gene and can translate directly in the host cell’s cytoplasm to produce the target antigen. Several side effects of this type of vaccine have been reported in the literature, including renal complications. However, acute tubulointerstitial nephritis is a very rare complication of COVID-19 mRNA vaccine. Here we present a 50-year-old, previously healthy female who presented with renal failure following a COVID-19 mRNA BNT162b2 (Pfizer-BioNTech) vaccination and diagnosed as acute tubulointerstitial nephritis in the kidney biopsy. To the best of our knowledge, only two cases of acute tubulointerstitial nephritis following COVID-19 vaccine have been reported and one of them had an underlying kidney disease. This is the second case of acute tubulointerstitial nephritis following COVID-19 vaccine in a healthy individual.","PeriodicalId":16515,"journal":{"name":"Journal of Nephropathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47499396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histopathological changes in the kidney tissues of White Swiss Mice (Mus musculus L.) exposed to α-Cypermethrin α-氯氰菊酯对瑞士小白鼠肾脏组织的影响
Journal of Nephropathology Pub Date : 2022-05-31 DOI: 10.34172/jnp.2022.17303
Maysoon Hussein Zain, Saphia Ali Aitte
{"title":"Histopathological changes in the kidney tissues of White Swiss Mice (Mus musculus L.) exposed to α-Cypermethrin","authors":"Maysoon Hussein Zain, Saphia Ali Aitte","doi":"10.34172/jnp.2022.17303","DOIUrl":"https://doi.org/10.34172/jnp.2022.17303","url":null,"abstract":"α- Cypermethrin is a pyrethroid insecticide. Chronic exposure to α -cypermethrin for use in household pest control or through drinking water and fruits and vegetables contaminated with it. The kidneys are an essential organ in the human and animal body because they perform a number of major functions. One of the causes of nephrotoxicity is exposure to environmental pollutants, which often lead to direct injury to the kidney tissues, causing pathological changes. The current study was designed to investigate the deleterious effects of α- Cypermethrin when taken in two doses in the kidney tissues of Swiss laboratory mice. And the Humasan method was used to prepare the tissue sections of the kidney. Treated mice groups showed many Histopathological changes in kidney, among these in low dose in females the shrinkage of some tubular cells nuclei and necrosis of others with vacuolization in cytoplasm of cells in the glomerular shape, the emergence of a clumping of mesenchymal cells in many regions with increased tubular cells enlargement. The effects varied in the form of bleeding at one time, congestion and edema at other times and aggregation of fat cells of different sizes and inflammation and death of renal cells. In males the effects varied in the form of loss of the glomerulus, congestion and dilation of Bowman's space, glomerular necrosis or loss of glomerulus,Hemorrhage congestion, renal cell death and cells hyperplasia. In females and males at high doses, the effects in females were represented by swelling of tubular cells, loss of the glomerulus, death of tubular cells again and loss of the renal glomeruli while in males they were represented by hemorrhage and death of the renal epithelium, loss of the glomerulus and congestion of its tubules. The results of this study confirmed that α- Cypermethrin causes seriously deteriorate in Kidney tissues of Albino Swiss mice.","PeriodicalId":16515,"journal":{"name":"Journal of Nephropathology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46945383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信